NSE · AGARWALEYE
Dr. Agarwal's Health Care Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹383 Cr with net profit ₹17 Cr — a 4.36% net margin, versus 3.05% the period before.
Shareholding
As of 2026-06-30
- Promoter32.34%
- Public1.98%
- FII57.96%
- DII7.72%
42,492 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.42× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #12 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,048 Cr | 60.38 | 13.42 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,000 Cr | 67.47 | 9.4 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹94,359 Cr | 100.61 | 5.73 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,025 Cr | 62.83 | 6.77 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,652 Cr | 171.83 | 15.81 | 8.48% | 6.54% |
| Global Health Limited | ₹38,911 Cr | 67.98 | 9.82 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,199 Cr | 44.31 | 8.41 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,296 Cr | 154.72 | 8.62 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,042 Cr | 56.97 | 12.78 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,613 Cr | 55.04 | 5.67 | 10.37% | 15.77% |
| Dr. Agarwal's Health Care Limited(this company) | ₹16,118 Cr | 109.33 | 7.94 | 6.58% | 6.72% |
AI analysis
AI-generated · google/gemini-2.5-flashDr. Agarwal's Health Care Limited (AGARWALEYE) has a market capitalization of Rs 15366 Cr. The company reported revenue of Rs 1757.02 Cr and a profit margin of 6.4%. Its P/E ratio stands at 387.76, with an EPS of 4.17. The book value per share is Rs 63.89, and it has a debt-to-equity ratio of 0.6.
Positives
- +Revenue grew by 28.4% annually.
- +Debt-to-equity ratio is 0.6.
Negatives
- −The profit margin is 6.4%, which is relatively low.
- −Promoter holding decreased from 32.4504% in March 2025 to 32.3374% in June 2026.
- −The Return on Equity (ROE) is 6.58% and Return on Capital Employed (ROCE) is 9.75%, indicating moderate capital efficiency.
- −Public shareholding is 1.9788%, which is relatively low.
Financial performance
The company's revenue grew by 28.4%. Annual revenue for the period ending Mar 2025 was Rs 1757.02 Cr, with a net profit of Rs 83.46 Cr. For the quarter ending Mar 2026, revenue was Rs 564.11 Cr, generating a net profit of Rs 39.71 Cr. The EBITDA for the same quarter was Rs 97.37 Cr.
Profitability & Returns
Dr. Agarwal's Health Care Limited recorded a Return on Equity (ROE) of 6.58% and a Return on Capital Employed (ROCE) of 9.75%. The overall profit margin was 6.4%. The diluted EPS for the period was Rs 4.17.
Balance Sheet
The company's debt-to-equity ratio is 0.6. The book value per share is Rs 63.89. No dividend yield was reported.
Ownership & Pledges
Institutional holding stands at 65.6838%. There were no promoter share pledges reported.
Data as of — price: 2026-09-12 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Dr. Agarwal's Health Care Limitedshare price & fundamentals